New Delhi, July 3 -- LogicFlo AI, a Boston-based AI platform designed specifically for the life sciences sector, has raised $2.7 million in a seed round led by Lightspeed, with participation from leading healthcare and enterprise AI investors. The funding will support LogicFlo AI's global expansion across pharmaceutical, biotech, and medtech organizations, and enable deeper deployment with global clients, including a Fortune 500 company already under contract.

Founded by Udith Vaidyanathan and Arun Ramakrishnan, the company is redefining how regulated scientific work is done by replacing fragmented tools and repetitive processes with intelligent AI agents that work under human guidance. Across regulatory affairs, medical writing, quality...